Copy right protected Page 1

Size: px
Start display at page:

Download "Copy right protected Page 1"

Transcription

1 DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful. 80% of ulcers are associated with Helicobacter pylori, a spiral-shaped bacterium that lives in the acidic environment of the stomach. A history of heartburn, gastroesophageal reflux disease (GERD) and use of certain forms of medication can raise the suspicion for peptic ulcer. Medicines associated with peptic ulcer include NSAID (non-steroid anti-inflammatory drugs) that inhibit cyclooxygenase, and most glucocorticoids (e.g. dexamethasone and prednisolone). A gastric ulcer would give epigastric pain during the meal, as gastric acid is secreted, or after the meal, as the alkaline duodenal contents reflux into the stomach. Symptoms of duodenal ulcers would manifest mostly before the meal when acid (production stimulated by hunger) is passed into the duodenum. An esophagogastroduodenoscopy (EGD), a form of endoscopy, also known as a gastroscopy, is carried out on patients in whom a peptic ulcer is suspected. Signs and symptoms are bloating and abdominal fullness, N/V, hematemesis and melena (tarry, foul-smelling feces due to oxidized iron from hemoglobin). The goals of PUD therapy include healing the ulcer and eliminating the cause of the ulcer. Nonpharmacological Treatment: Life style modifications should be continued throughout treatment. Before sleeping: elevate the head of bed to increase esophageal clearance avoid fats, chocolate, alcohol and spearmint avoid spicy foods, orange juice, coffee and excessive tea eat small meals and avoid eating immediately prior sleeping (2 3 hours) lose weight and stop smoking avoid tight fitting clothes Pharmacological Treatment: Antacids and alginic acid: effective in GERD Name Efficacy/Dosage Side Effects Interactions Monitoring/Comments Al(OH) 3 CaCO 3 Only effective for immediate symptomatic relief Not effective for ulcer bleeding or prevention Calcium containing antacid cause rebound acidy and constipation Magnesium containing Decrease bioavailability of digoxin, quniolones, tetracyclines, FQs, Alginate and sodium antacids contain amount of sodium. Alginates form a viscous solution that floats on the surface of the gastric content. Copy right protected Page 1

2 Mg(OH) 2 Na(HCO) 3 30 ml PRN or pc and hs or 2 tabs pc and HS Gaviscon is not a potent acid neutralizing agent. Frequent administration and treatment time is antacids cause diarrhea Aluminum containing antacids cause diarrhea Sodium may be a concern for hypertensive Hypophosphetemia is a concern on long term use of aluminum containing antacids H 2 Receptor Antagonists: block secretion of histamine 2 receptors on parietal cells. Cimetidine (Tegamet) anticholinerigcs and others Separate drugs two hours before or 3 hours after antacids. Magnesium and aluminum antacid are preferred agents. Sodium bicarbonate is contraindicated in HF, severe renal disease, HTN and edema Avoid magnesium containing antacids in renal failure. Alginic acids and aluminum antacids are safe in pregnancy. Higher doses and prolonged Gynecomastia CYP 450 courses are frequently required Impotence inhibitors Effective in mild GERD and gastric ulcer 300 mg BID PO 400 mg OD PO Famotidine (Pepcid) 10, 20 mg tab Nizatidine (Axid) Short-term treatment of active duodenal ulcer, active benign gastric ulcer and GERD up to 4 6 weeks. The most potent agent 20 mg OD BID PO HS Axid is indicated for up to 8 weeks for the treatment of active duodenal ulcer. Axid is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis Axid is indicated for up to 8 Cimetidine inhibits metabolism of theophylline, warfarin, phenytoin, nifetidine and propranolol Can be used in pregnancy in lower dose Ranitidine should be used cautiously in hepatic impairment Treatment time is 2 8 weeks for all agents despite healing. The plasma half-life of ranitidine is prolonged and total clearance is reduced in the elderly population due to a decrease in renal function. Copy right protected Page 2

3 Ranitidine (Zantec) 75, 150 and 300 mg weeks for the treatment of active benign gastric ulcer. 150 mg OD BID PO The elimination half-life is 3 to 4 hours. The recommended oral dose for the treatment of active duodenal and gastric ulcers is 300 mg/day. 150 mg OD BID PO Proton Pump Inhibitors: block gastric acid secretion by inhibiting H + /K + ATPase in gastric parietal cells. Omeprazole (Losec) Lansoprazole (Prevacid) Pantoprazole (Pantoloc) Rabeprazole (Pariet) Esomeprazole (Nexium) Most effective agents All agents are taken 30 minutes before breakfast in the morning Effective for gastric ulcers, GERD (heart burn) and Zollinger Ellison Syndrome Omeprazole: mg OD PO Pantaprazole: 40 mg/d PO Lansoprazole: 30 mg/d PO Esomperazole: mg/d PO Rabeprazole: mg/d PO Omeprazole is approved in children ages 2 16 years Lansoprazole is approved in children ages 1 11 years Treatment time is 4 8 weeks despite healing Very safe but occasionally cause Dizziness Constipation Not very significant PPIs degraded in acidic environments and are formulated in delayed release caps or tabs. Patients are advised not to chew or crush. Lansoprazole and omeprazole are in granules in capsule and can be mixed in applesauce or placed in orange juice. Pantoprazole is available IV for immediate relief and who can t take oral form If PPIs are dosed twice daily then second dose should be taken 12 hr apart before snack or meal PPIs can be taken concomitantly with antacids. Among PPIs omeprazole is the most potent. Gastric Mucosal Protectant: Copy right protected Page 3

4 Sucralfate PG Analog: It is a nonabsorable aluminum salt of sucrose octasulfate Use for stress ulcer Taken on empty stomach 1 g BID to QID Well tolerated Constipation Antacids bind sucralfate Ketoconazole Warfarin Digoxin Theophylline binds to sucralfate Very limited value is GERD Should be spaced 2 hr apart from other medications Protects ulcerated tissue by forming a barrier or coating Misoprostol (Cytotec) PGE 1 analog Most effective prophylaxis for both gastric and duodenal ulcers Has both antisecreotry and mucosal protective property Given for NSAIDs induced ulcers mcg QID PO with meals Abdominal cramps Absolute contraindicated in pregnancy Motility Agents: Domperidone (Motilium) DA antagonist GIT: Suppress nausea and vomiting 10 mg TID ac & hs Prescribed for the treatment of gastroparesis Lactation: Domperidone, by acting as an antidopaminergic, results in increased prolactin secretion, and thus promotes lactation 10 mg TID QID after breastfeeding Poor CNS penetration Dry mouth MAO Inhibitors Anticholinergics Abdominal cramps Prolactinoma Safe in breastfeeding Obstruction of bowel or perforation Onset of action is in few days Copy right protected Page 4

5 Metoclopramide (Reglan) Tab, injection Prokinectic agent GERD & gastroparesis Chemotherapy induced vomiting Metoclopramide acts on D 2 receptors and in the higher doses enters CTZ in the brainstem, thus blocking nausea/vomiting, enhances the response to ACh to tissues in upper GIT causing enhanced motility, increase gastric emptying and lower esophageal sphincter tone GIT: 5 10 mg TID ac & hs continue for 2 8 weeks PRN Drowsiness Dizziness EPS (Parkinson s symptoms) GI upset Combination therapy to eradicate H. pylori H. pylori is a gram negative bacterium. For diagnosis noninvasive tests (breath test and serology) and invasive test (endoscopy) are used. Drug Combination Dose and Frequency Duration Efficacy Lansoprazole Amoxicillin Clarithromycin 30 mg BID 1 g TID 500 mg BID Esomeprazole Amoxicillin Clarithromycin Bismuth subsalicylate Metronidazole Tetracycline Omeprazole 40 mg qd 1 g BID 500 mg BID 525 mg QID 250 mg QID 500 mg QID 20 mg BID Epilepsy Obstruction or bowel perforation Avoid alcohol Watch dystonic reactions Pheochromocytoma Caution is seizures Avoid with alcohol and CNS agents Copy right protected Page 5

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

More information

Reflux of gastric contents, particularly acid, into the esophagus

Reflux of gastric contents, particularly acid, into the esophagus Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,

More information

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:

More information

Peptic ulcer disease Disorders of the esophagus

Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth

More information

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer. Pharmacology - Problem Drill 21: Drugs Used To Treat GI Disorders No. 1 of 10 1. Endogenous secretagogues for stomach acid include: #01 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Histamine

More information

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011 KK College of Nursing Peptic Ulcer Badil Dass, Lecturer 25 th July, 2011 Objectives: By the end of this lecture, the students t will be able to: Define peptic pp ulcer Describe the etiology and pathology

More information

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both

More information

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018 GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Drugs Used in Gastrointestinal Diseases Drugs used in Peptic Ulcer Diseases. Drugs Stimulating Gastrointestinal Motility &Laxatives. Antidiarrheal Agents. Drugs

More information

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials. Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs

More information

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority

More information

Chapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases

Chapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases Chapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases p1009 DRUGS USED IN ACID-PEPTIC DISEASES 1. classification of drugs 2. agents that reduce intragastric acidity Antacids,H 2 antagonists,proton

More information

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many

More information

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia

More information

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018 GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Z Gastroenterol. 1983 Mar;21 Suppl:111-6. [Effect of antacids on intestinal motility]. [Article in German] Wienbeck M, Erckenbrecht J, Strohmeyer G. Abstract

More information

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus.

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus. WHILE almost everyone experiences mild heartburn from time to time and many individuals have some antacids or another medication on hand for its relief, talk to your doctor, if you have heartburn more

More information

UPPER GI DISEASES 11/15/2014. Lesson Objectives. GI Tract Review. NUTR 2050 Nutrition for Nursing Professionals. Mrs. Deborah A. Hutcheon, MS, RD, LD

UPPER GI DISEASES 11/15/2014. Lesson Objectives. GI Tract Review. NUTR 2050 Nutrition for Nursing Professionals. Mrs. Deborah A. Hutcheon, MS, RD, LD UPPER GI DISEASES NUTR 2050 Nutrition for Nursing Professionals Mrs. Deborah A. Hutcheon, MS, RD, LD Lesson Objectives At the end of the lesson, the student will be able to: 1. Describe causes and contributing

More information

Lab:2 Drugs acting on Gastrointestinal tract

Lab:2 Drugs acting on Gastrointestinal tract Lab:2 Drugs acting on Gastrointestinal tract Drugs that used to treat three common medical conditions involving the gastrointestinal tract: peptic ulcers and gastroesophageal reflux disease (GERD), chemotherapy-induced

More information

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.09.01 Subject: Proton Pump Inhibitors Page: 1 of 7 Last Review Date: June 12, 2014 Proton Pump Inhibitors

More information

SASKATCHEWAN REGISTERED NURSES ASSOCIATION

SASKATCHEWAN REGISTERED NURSES ASSOCIATION DEFINITION Reflux of gastric contents into the esophagus, which results in esophageal irritation or inflammation. IMMEDIATE CONSULTATION REQUIRED IN THE FOLLOWING SITUATIONS Dysphagia (solid food, progressive)

More information

Difference between omeprazole and omeprazole delayed release

Difference between omeprazole and omeprazole delayed release Cari untuk: Cari Cari Difference between omeprazole and omeprazole delayed release 7-2-2018 Easy to read patient leaflet for Omeprazole Delayed-Release Capsules. Includes indications, proper use, special

More information

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35. An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology

More information

- Ali Yaghi. - Sara Yaghi. - Alia Shatnawi. 1 P a g e

- Ali Yaghi. - Sara Yaghi. - Alia Shatnawi. 1 P a g e -2 - Ali Yaghi - Sara Yaghi - Alia Shatnawi 1 P a g e We ended the previous lecture with H2 receptor antagonists, which work by selectively inhibiting H2 receptors. They are widely used to treat: 1- GERD,

More information

CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)?

CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? A. Chronic alcohol ingestion B. Nonsteroidal antiinflammatory

More information

Second term/

Second term/ Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic

More information

Drug Class Monograph

Drug Class Monograph Drug Class Monograph Class: Proton Pump Inhibitors Drugs: Aciphex Sprinkle (rabeprazole), Dexilant (dexlansoprazole), Lansoprazole, Nexium (esomeprazole capsule, esomeprazole granules), Omeprazole, Pantoprazole,

More information

National Digestive Diseases Information Clearinghouse

National Digestive Diseases Information Clearinghouse Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach

More information

QUICK QUERIES. Topical Questions, Sound Answers

QUICK QUERIES. Topical Questions, Sound Answers QUICK QUERIES Topical Questions, Sound Answers Dyspepsia: An Evidence-Based Approach Alan B. R. Thomson, MD, PhD, FRCPC, FACP, FACG Presented at the University of Alberta s Medical Grand Rounds, University

More information

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) Gastroesophageal Reflux Disease (GERD) Information for patients UHN Read this handout to learn about: What gastroesohageal reflux (GERD) is Signs and symptoms How your doctor will know if you have it Tests

More information

MEDICATION GUIDE Lansoprazole Delayed-Release Capsules, USP

MEDICATION GUIDE Lansoprazole Delayed-Release Capsules, USP MEDICATION GUIDE Lansoprazole Delayed-Release Capsules, USP Read this Medication Guide before you start taking lansoprazole delayed-release capsules and each time you get a refill. There may be new information.

More information

Heartburn Overview. Causes & Risk Factors

Heartburn Overview. Causes & Risk Factors Return to Web version Heartburn Overview What is heartburn? Despite its name, heartburn doesn't affect the heart. Heartburn is a burning feeling in the lower chest, along with a sour or bitter taste in

More information

What Is Peptic Ulcer Disease?

What Is Peptic Ulcer Disease? What Is Peptic Ulcer Disease? Peptic ulcer disease is when painful sores form in the lining of the stomach, duodenum (start of the small intestine) or bowels. An ulcer can cause belly pain and, in some

More information

Proton Pump Inhibitors Drug Class Prior Authorization Protocol

Proton Pump Inhibitors Drug Class Prior Authorization Protocol Proton Pump Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: November 15, 2017 Effective Date: January 1, 2018 This policy has been developed through review

More information

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults hur till återvinna från prostataoperation Is This Information Right for Me? Yes, if: A doctor said that you have gastroesophageal

More information

Management of Dyspepsia

Management of Dyspepsia MPharm Programme Management of Dyspepsia Slide 1 of 28 Learning Objectives Understand the principles and wider implications underpinning evidence based therapeutics in the key clinical specialities Objectively

More information

* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte.

* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte. Trade Name Aciloc 75 mg & 300 mg Film-coated tablets Generic Name Ranitidine Composition Each Aciloc 300 mg film-coated tablet contains: - Active ingredient: Ranitidine hydrochloride 336 mg equivalent

More information

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées OPTIMAL THERAPY REPORT COMPUS Volume 1, Issue 5 March 2007 Current Practice Analysis Report for the Prescribing and Use of Proton Pump Inhibitors (PPIs) Supporting Informed Decisions À l appui des décisions

More information

Proton Pump Inhibitors. Description

Proton Pump Inhibitors. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.01 Subject: Proton Pump Inhibitors Page: 1 of 6 Last Review Date: June 24, 2015 Proton Pump Inhibitors

More information

Peptic Ulcer Disease Update

Peptic Ulcer Disease Update Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following

More information

Epidemiology of Peptic Ulcer Disease

Epidemiology of Peptic Ulcer Disease Epidemiology of Peptic Ulcer Disease Introduction Peptic Ulcer Disease (PUD) is disruption of the mucosal integrity of the stomach and/or duodenum leading to a local defect or excavation due to active

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release capsule (Manufacturer s standard)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release capsule (Manufacturer s standard) READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr PREVACID lansoprazole delayed-release capsule (Manufacturer s standard) Read this carefully before you start taking

More information

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group)

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group) Proton Pump Inhibitors (PPIs) (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf

More information

You May Be at Risk. You are currently taking a proton-pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Pantoprazole (Pantoloc, Panto IV )

You May Be at Risk. You are currently taking a proton-pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Pantoprazole (Pantoloc, Panto IV ) You May Be at Risk. You are currently taking a proton-pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Esomeprazole (Nexium ) Omeprazole (Losec, Olex ) Pantoprazole (Pantoloc, Panto IV ) Pantoprazole

More information

Page 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Acid reflux (gastroesophageal reflux disease) in adults (The Basics) Written by the doctors and editors at UpToDate

More information

POCKET HANDBOOK OF GI PHARMACOTHERAPEUTICS

POCKET HANDBOOK OF GI PHARMACOTHERAPEUTICS POCKET HANDBOOK OF GI PHARMACOTHERAPEUTICS CLINICAL GASTROENTEROLOGY GEORGE Y. WU, SERIES EDITOR For other titles published in this series, go to www.springer.com/series/7672 POCKET HANDBOOK OF GI PHARMACOTHERAPEUTICS

More information

Pharmacology. Drugs that Affect the Gastrointestinal System

Pharmacology. Drugs that Affect the Gastrointestinal System Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against

More information

Policy Evaluation: Proton Pump Inhibitors (PPIs)

Policy Evaluation: Proton Pump Inhibitors (PPIs) Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the

GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the GERD What is GERD? Gastroesophageal reflux disease, or GERD, occurs when acid from the stomach backs up into the esophagus. Normally, food travels from the mouth, down through the esophagus and into the

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. PROTON PUMP INHIBITORS, NON-PREFERRED FORMS: ACIPHEX (rabeprazole sodium EC) oral tablet ACIPHEX SPRINKLE (rabeprazole sodium DR) oral capsule ESOMEPRAZOLE STRONTIUM (esomeprazole strontium DR) oral capsule

More information

All pharmacodynamic effects observed can be explained by the effect of omeprazole on acid secretion.

All pharmacodynamic effects observed can be explained by the effect of omeprazole on acid secretion. OMEPRAZOLE Losec 10mg and 20mg Capsules Acid Pump Inhibitors FORMULATION Each capsule contains Omeprazole 10 mg or 20 mg. PHARMACEUTICAL FORM Omeprazole (LOSEC) capsule 10 mg: hard gelatin capsule with

More information

OSPAP Programme. Gastrointestinal Drugs. Dr. Adrian Moore Dale

OSPAP Programme. Gastrointestinal Drugs. Dr. Adrian Moore Dale PAP Programme Dr. Adrian Moore Dale 1.03 Adrian.Moore@sunderland.ac.uk 0191 5152554 lide 1 of 26 PAP MPM14 Acid-Related Pathophysiology The stomach secretes: ydrochloric acid (Cl) aids digestion and also

More information

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives Esomeprazole 20mg Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8886Q) (029W) Gastric ulcer Peptic ulcer Treatment Phase: Initial treatment The therapy must be for initial treatment

More information

MEDICATION GUIDE. PREVACID can have other serious side effects. See What are the possible side effects of PREVACID?

MEDICATION GUIDE. PREVACID can have other serious side effects. See What are the possible side effects of PREVACID? Page 33 of 39 MEDICATION GUIDE PREVACID (prev-a-sid) (lansoprazole) Delayed-Release Capsules and PREVACID SoluTab (prev-a-sid sol-u-tab) (lansoprazole) Delayed-Release Orally Disintegrating Tablets Read

More information

-Mohammad Ashraf. -Anas Raed. -Alia Shatnawi. 1 P a g e

-Mohammad Ashraf. -Anas Raed. -Alia Shatnawi. 1 P a g e -1 -Mohammad Ashraf -Anas Raed -Alia Shatnawi 1 P a g e Dr. Alia started the lecture by talking about subjects we are going to cover through this course; you can refer to the record if you are interested.

More information

Case 4: Peptic Ulcer Disease. Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie

Case 4: Peptic Ulcer Disease. Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie Case 4: Peptic Ulcer Disease Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie Case 4: PUD Problem List: 1. Peptic Ulcer Disease SOAP Note: S Patient is complaining of abdominal pain

More information

Medication Guide Lansoprazole Delayed-Release Capsules, USP (lanz-ah-pray-zol)

Medication Guide Lansoprazole Delayed-Release Capsules, USP (lanz-ah-pray-zol) Medication Guide Lansoprazole Delayed-Release Capsules, USP (lanz-ah-pray-zol) Read this Medication Guide before you start taking lansoprazole delayed-release capsules and each time you get a refill. There

More information

PREVACID is used in children and adolescents (ages 1 to 17): for up to 12 weeks to treat GERD and erosive esophagitis in children 1 to 11 years old.

PREVACID is used in children and adolescents (ages 1 to 17): for up to 12 weeks to treat GERD and erosive esophagitis in children 1 to 11 years old. MEDICATION GUIDE PREVACID (prev-a-sid) Delayed-Release Capsules and PREVACID SoluTab (prev-a-sid sol-u-tab) Delayed-Release Orally Disintegrating Tablets Read this Medication Guide before you start taking

More information

You May Be at Risk. You are currently taking a proton pump inhibitor (PPI):

You May Be at Risk. You are currently taking a proton pump inhibitor (PPI): PPI You are currently taking a proton pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Esomeprazole (Nexium ) Omeprazole (Losec, Olex ) Lansoprazole (Prevacid, Prevacid Fast Tab ) Pantoprazole sodium

More information

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE Definition A circumscribed ulceration of the gastrointestinal mucosa occurring in areas exposed to acid and pepsin and most often caused

More information

What is Neratinib (ne-ra-ti-nib) and how does it work?

What is Neratinib (ne-ra-ti-nib) and how does it work? PATIENT EDUCATION patienteducation.osumc.edu What is (ne-ra-ti-nib) and how does it work? is a type of oral, targeted cancer therapy called a tyrosine kinase inhibitor. Another name for this drug is Nerlynx.

More information

Gastric ulcer: The recommended dosage is Pepzol 20 mg once daily. Symptom resolution is rapid and in most

Gastric ulcer: The recommended dosage is Pepzol 20 mg once daily. Symptom resolution is rapid and in most Name Pepzol (Omeprazole) 20 mg, 40 mg Modified release (MR) Capsules Composition Each capsule Contains: Omeprazole 20 mg or 40 mg For excipients see "list of excipients" Pharmaceutical form Pepzol capsules

More information

Management of dyspepsia in adults in primary care

Management of dyspepsia in adults in primary care Dyspepsia Management of dyspepsia in adults in primary care June 2005. The recommendations on referral for endoscopy in this NICE guideline have been amended in line with the recommendation in the NICE

More information

Management of dyspepsia and of Helicobacter pylori infection

Management of dyspepsia and of Helicobacter pylori infection Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia

More information

Ranitidine hydrochloride syrup containing 150mg Ranitidine per 10mL

Ranitidine hydrochloride syrup containing 150mg Ranitidine per 10mL Peptisoothe Ranitidine hydrochloride syrup containing 150mg Ranitidine per 10mL Presentation PEPTISOOTHE is a clear to pale yellow syrup with a spearmint flavour. Each 10mL of the syrup contains ranitidine

More information

Esomeprazole strontium can have other serious side effects. See What are the possible side effects of esomeprazole strontium?

Esomeprazole strontium can have other serious side effects. See What are the possible side effects of esomeprazole strontium? MEDICATION GUIDE ESOMEPRAZOLE STRONTIUM (es-o-mep-ra-zol stron-tee-um) delayed-release capsules Read the Medication Guide that comes with esomeprazole strontium before you start taking esomeprazole strontium

More information

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI) Outline Quick basics on Proton Pump Inhibitors (PPIs) PPIs: Good or Bad? What are potential risks of PPI therapy? How to approach your patients American Gastroenterology Association (AGA) recommendations

More information

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty. Omeprazole 10mg Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form omeprazole

More information

All Indiana Medicaid Prescribers and Pharmacy Providers

All Indiana Medicaid Prescribers and Pharmacy Providers P R O V I D E R B U L L E T I N BT200148 NOVEMBER 28, 2001 To: All Indiana Medicaid Prescribers and Pharmacy Providers Subject: Note: The information in this bulletin regarding prior authorization payment

More information

PLANNING COMMITTEE. Seek simplicity, and mistrust it. Alfred North Whitehead

PLANNING COMMITTEE. Seek simplicity, and mistrust it. Alfred North Whitehead PLANNING COMMITTEE 1. Content Experts Clinical experts Desmond Leddin MB FRCPC, Head, Division of Gastroenterology, Dalhousie University Drug evaluation pharmacist Pam McLean-Veysey BScPharm, Drug Evaluation

More information

LOSEC MUPS 10 mg, 20 mg and 40 mg Tablets ASTRAZENECA

LOSEC MUPS 10 mg, 20 mg and 40 mg Tablets ASTRAZENECA 10-14 LOSEC MUPS 10 mg, 20 mg and 40 mg Tablets ASTRAZENECA omeprazole Tablets Composition Each tablet contains: Omeprazole magnesium 10.3 mg, 20.6 mg and 41.3 mg (corresponding to omeprazole 10 mg, 20

More information

Pthaigastro.org. Evolution of antisecretory agents. History. Antacids and anticholinergic drugs

Pthaigastro.org. Evolution of antisecretory agents. History. Antacids and anticholinergic drugs Evolution of antisecretory agents uthapong Ukarapol, MD. Division of Gastroenterology Chiang Mai University istory 1823- Prout discovered gastric hydrochloric acid 1875- eidenhain and 1893- Golgi identified

More information

Proton Pump Inhibitor De-prescribing Guidance

Proton Pump Inhibitor De-prescribing Guidance Amendment History Proton Pump Inhibitor De-prescribing Guidance VERSION DATE AMENDMENT HISTORY 1.0 2013 Previous version 2.0 September 2015 Comments Amendment to Flow chart and addition of Rationale page

More information

Rpts. GENERAL General Schedule (Code GE)

Rpts. GENERAL General Schedule (Code GE) Pantoprazole 20mg Name, Restriction, Manner of administration and form Pantoprazole 20mg enteric tablet, 30 (8399C) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form

More information

SUCRALFATE TABLETS, USP

SUCRALFATE TABLETS, USP 1234567890 10 210002-01 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:

More information

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Dyspepsia refers to a broad range of symptoms related

More information

SUCRALFATE TABLETS, USP

SUCRALFATE TABLETS, USP 1234567890 10 210002 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:

More information

Summary of Findings on the Prescribing and Use of Proton Pump Inhibitors. COMPUS Interim Report CCOHTA. March 6, 2006

Summary of Findings on the Prescribing and Use of Proton Pump Inhibitors. COMPUS Interim Report CCOHTA. March 6, 2006 Summary of Findings on the Prescribing and Use of Proton Pump Inhibitors COMPUS Interim Report CCOHTA March 6, 2006 Note that the information presented in this document does not constitute recommendations

More information

MEDICATION GUIDE. Rabeprazole Sodium Delayed-Release Tablets Rx Only

MEDICATION GUIDE. Rabeprazole Sodium Delayed-Release Tablets Rx Only MEDICATION GUIDE Rabeprazole Sodium Delayed-Release Tablets Rx Only Read the Medication Guide that comes with rabeprazole sodium delayed-release tablets before you start taking it and each time you get

More information

Peptic Ulcer Disease and NSAIDs

Peptic Ulcer Disease and NSAIDs Peptic Ulcer Disease and NSAIDs National Digestive Diseases Information Clearinghouse What is a peptic ulcer? A peptic ulcer is a sore on the inner lining of the stomach or duodenum the first part of the

More information

EU RISK MANAGEMENT PLAN (EU RMP)

EU RISK MANAGEMENT PLAN (EU RMP) EU RISK MANAGEMENT PLAN (EU RMP) Active substance(s) (INN or common name): Esomeprazole Pharmaco-therapeutic group (ATC Code): A02B C05 Name of Marketing Authorisation Holder or Applicant: Strength and

More information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information James Paget University Hospitals NHS Foundation Trust Hiatus hernia Patient Information What is a hiatus hernia? A hiatus hernia can cause highly irritating stomach contents, such as acid, to move up into

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.CPA.209 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important

More information

Gastrointestinal Pharmacology

Gastrointestinal Pharmacology Gastrointestinal Pharmacology Jan Kehr Department of Physiology and Pharmacology Gastrointestinal Pharmacology v Background v Peptic disorders v Constipation and Diarrhea v Chronic Bowel Disease Gastrointestinal

More information

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School No disclosures Disclosures Overview Causes of peptic ulcer disease

More information

June By: Reza Gholami

June By: Reza Gholami ACG/CAG guideline on Management of Dyspepsia June 2017 By: Reza Gholami DEFINITION OF DYSPEPSIA AND SCOPE OF THE GUIDELINE Dyspepsia was originally defined as any symptoms referable to the upper gastrointestinal

More information

Developing Evidence-Based Best Practices for the Prescribing and Use of Proton Pump Inhibitors in Canada

Developing Evidence-Based Best Practices for the Prescribing and Use of Proton Pump Inhibitors in Canada Developing Evidence-Based Best Practices for the Prescribing and Use of Proton Pump Inhibitors in Canada Presented by: Sumeet R. Singh, COMPUS April 4, 2006 Background COMPUS Objective: To identify and

More information

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 Patient information Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 You have been diagnosed with laryngopharyngeal reflux (LPR), otherwise known as extra-oesophageal reflux

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release tablet

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release tablet READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr PREVACID FasTab lansoprazole delayed-release tablet Read this carefully before you start taking PREVACID FasTab and

More information

MEDICATION GUIDE Lansoprazole (lan-so-pruh-zole) Delayed-release Capsules, USP

MEDICATION GUIDE Lansoprazole (lan-so-pruh-zole) Delayed-release Capsules, USP MEDICATION GUIDE Lansoprazole (lan-so-pruh-zole) Delayed-release Capsules, USP Read this Medication Guide before you start taking lansoprazole delayed-release capsules and each time you get a refill. There

More information

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee Guidelines for the Management of Dyspepsia and GORD Document type: Version: 3.0 Author (name): Author (designation): Validated by Prescribing Dr. G. Lipscomb Date validated October 2015 Ratified by: Date

More information

SUCRALFATE ISELPIN 1 g Tablet

SUCRALFATE ISELPIN 1 g Tablet 1.0 PHARMACOLOGIC CATEGORY CYTOPROTECTOR 2.0 DESCRIPTION SUCRALFATE ISELPIN 1 g Tablet Sucralfate is a white, amorphous powder which is soluble in strong acids and in alkalis but practically insoluble

More information

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées OPTIMAL THERAPY REPORT COMPUS Volume 1, Issue 6 March 2007 Gap Analysis Report for the Prescribing and Use of Proton Pump Inhibitors (PPIs) Supporting Informed Decisions À l appui des décisions éclairées

More information

Information for patients having a Gastroscopy

Information for patients having a Gastroscopy Information for patients having a Gastroscopy This leaflet has been prepared to enable you to make an informed decision when you are asked to give consent to the procedure. If you find you have any questions

More information

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people What Is Dyspepsia? Dyspepsia, also known as indigestion, can have multiple symptoms. Feelings of indigestion happen during or after eating. If you have indigestion you might feel: Full during a meal. Painful

More information

NEGATIVE ENDOSCOPY, What is the Diagnosis and Treatment?

NEGATIVE ENDOSCOPY, What is the Diagnosis and Treatment? NEGATIVE ENDOSCOPY, PPI REFRACTORY REFLUX: What is the Diagnosis and Treatment? Michael F. Vaezi, MD, PhD, MSc, FACG Professor of Medicine Clinical Director Division of Gastroenterology, Hepatology and

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Duexis) Reference Number: CP.PMN.120 Effective Date: 06.01.18 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea. Antacids Hawler medical university Collage of pharmacy/ fourth year /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information